TP53 and neoplasm: We showed that the master chaperone involved in the UPR and associated with cell survival, glucose-regulated protein (GRP) of 78 KDa (GRP78) increased in response to mifepristone in a dose- and time-dependent manner, and independently of p53 tumor suppressor and sensitivity to chemotherapeutic agent cisplatin.